WHAT:

Meeting of the CDC′s Advisory Committee on Immunization Practices (ACIP)

WHEN:

June 27 - 28, 2007

WHERE:

Centers for Disease Control and Prevention
1600 Clifton Road NE
Atlanta, GA 30329
Tom Harkin Global Communications Center (Building 19), Room 232

AGENDA:

Hepatitis A Vaccine Prophylaxis

• The ACIP will consider recommendations to allow for the option of using hepatitis A vaccine instead of immune globulin (IG) after exposure to hepatitis A virus.

Adult Immunization Schedule

• ACIP will review and make recommendations for the 2007-08 Adult Immunization Schedule.

Influenza Vaccine

• ACIP will consider a possible change in recommendations for FluMist to include children younger than five years of age. (A FDA Warning letter sent to MedImmune regarding manufacturing issues (May 25, 2007) may delay a vote.)

Human Papillomavirus Vaccines

• Bivalent HPV vaccine - Update from the phase III vaccine efficacy trials. This will be the first time GSK will publicly present efficacy and safety data from their phase III trial.
• Quadrilvalent HPV vaccine - Update on clinical trials
• Post licensure quadrivalent HPV vaccine safety monitoring

Meningococcal Conjugate Vaccine

• The ACIP will consider a proposal to simplify the recommendation for Meningococcal Conjugate Vaccine (MCV4) by recommending routine vaccination of adolescents 11-18 years of age.

REGISTRATION:

To speed security clearance at CDC′s Clifton Road campus, ACIP attendees (participants and visitors) should register online at http://www.cdc.gov/nip/ACIP/dates.htm . You will receive a placard for your vehicle (parking tag) and instructions for navigating the secured CDC environment for attending the ACIP meeting once registration is complete.